Clinical Assessment: 47-Year-Old Menopausal Woman with Recurrent Pubic "Pimples"

Differential Diagnosis

1. 🔴 Hidradenitis Suppurativa (HS) — Most Important to Rule Out

• Chronic, recurrent condition involving the apocrine glands and terminal hair follicles
• Preferentially affects inguinal and vulvar folds in women
• Disproportionately affects women and peaks in the 18–29 age group, but persists into menopause
• Presents as tender, red nodules → become fluctuant → rupture → sinus tracts → scarring
• Hormonal factors play a role; postmenopausal women may benefit from finasteride as adjunct therapy

• Recurrent lesions in the same area
• Sinus tract formation on probing
• Scarring/hyperpigmentation between flares
• Bilateral distribution (vs. unilateral furuncles)

2. Folliculitis / Pseudofolliculitis ("Razor Bumps")

• Infectious folliculitis: caused by Staphylococcus aureus or Streptococcus pyogenes, often triggered by shaving pubic hair
• Pseudofolliculitis (mechanical): ingrown hairs causing an inflammatory papular reaction, especially common with shaving and in individuals with curly hair
• Ask about: pubic hair removal practices, shaving, waxing, laser

"Shaving and other methods of pubic hair removal are associated with razor burn, contact dermatitis, and transmission of infectious agents such as Molluscum contagiosum, HPV, and herpes simplex along with bacteria including Pseudomonas aeruginosa." — Berek & Novak's Gynecology

3. Fox–Fordyce Disease

• Chronic pruritic eruption of small papules/cysts from keratin-plugged apocrine glands
• Located over mons pubis, labia majora, lower abdomen, inner thighs
• Worsens with sweating and hormonal changes (can flare in menopause)

4. Other Conditions to Consider

Note: "The risk of malignant lesions increases with age — any lesion that appears atypical or where diagnosis is not clear should be analyzed by biopsy." — Berek & Novak's Gynecology

Menopause-Specific Considerations

• Estrogen deficiency → vulvovaginal atrophy → thinner, drier, more fragile skin → increased susceptibility to folliculitis and skin irritation
• Hormonal shifts can unmask or worsen HS and apocrine gland disorders
• Increased risk of secondary infections due to altered skin microenvironment

Recommended Workup

1. Detailed history: frequency, duration, recurrence pattern, hair removal practices, associated pain, discharge, systemic symptoms, family history
2. Physical exam: location, number, character of lesions, presence of sinus tracts, scarring, lymphadenopathy
3. Probe test: if deep nodules present → explore for burrowing sinus tracts (pathognomonic of HS)
4. Culture of purulent material if fluctuant
5. Biopsy of any atypical, pigmented, or non-resolving lesion
6. Screen for comorbidities: BMI, fasting glucose, HbA1c, lipids

Management Summary by Likely Diagnosis

• Daily wash with chlorhexidine gluconate or benzoyl peroxide
• Avoid friction: loose clothing, weight loss if needed
• Topical clindamycin + intralesional steroids for early lesions
• Oral doxycycline or minocycline
• Clindamycin + rifampicin (300 mg twice daily each) — extensively studied, effective
• Finasteride — specifically noted for postmenopausal women as a hormonal adjunct
• Spironolactone as adjunct
• Adalimumab (FDA approved, anti-TNF) for severe/refractory disease
• Incision and drainage is discouraged — promotes sinus tract formation
• Laser hair removal (in unaffected areas) as prevention

• Topical mupirocin or clindamycin
• Short course oral antibiotics if extensive (cephalexin, TMP-SMX)
• Advise against shaving; suggest trimming or alternative hair removal

• Topical retinoids, topical corticosteroids
• Eflornithine cream (reduces sweat gland activity)